rs10883841
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001351169.2(NT5C2):āc.7A>Gā(p.Thr3Ala) variant causes a missense change. The variant allele was found at a frequency of 0.128 in 1,597,198 control chromosomes in the GnomAD database, including 14,609 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.11 ( 1139 hom., cov: 32)
Exomes š: 0.13 ( 13470 hom. )
Consequence
NT5C2
NM_001351169.2 missense
NM_001351169.2 missense
Scores
5
13
Clinical Significance
Conservation
PhyloP100: 5.62
Genes affected
NT5C2 (HGNC:8022): (5'-nucleotidase, cytosolic II) This gene encodes a hydrolase that serves as an important role in cellular purine metabolism by acting primarily on inosine 5'-monophosphate and other purine nucleotides. [provided by RefSeq, Oct 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0016233623).
BP6
Variant 10-103174952-T-C is Benign according to our data. Variant chr10-103174952-T-C is described in ClinVar as [Benign]. Clinvar id is 380851.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-103174952-T-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.148 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NT5C2 | NM_001351169.2 | c.7A>G | p.Thr3Ala | missense_variant | 3/19 | ENST00000404739.8 | NP_001338098.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NT5C2 | ENST00000404739.8 | c.7A>G | p.Thr3Ala | missense_variant | 3/19 | 1 | NM_001351169.2 | ENSP00000383960.3 |
Frequencies
GnomAD3 genomes AF: 0.107 AC: 16318AN: 152084Hom.: 1138 Cov.: 32
GnomAD3 genomes
AF:
AC:
16318
AN:
152084
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.118 AC: 29236AN: 247866Hom.: 2013 AF XY: 0.118 AC XY: 15854AN XY: 133970
GnomAD3 exomes
AF:
AC:
29236
AN:
247866
Hom.:
AF XY:
AC XY:
15854
AN XY:
133970
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.130 AC: 187668AN: 1444996Hom.: 13470 Cov.: 27 AF XY: 0.128 AC XY: 92065AN XY: 719810
GnomAD4 exome
AF:
AC:
187668
AN:
1444996
Hom.:
Cov.:
27
AF XY:
AC XY:
92065
AN XY:
719810
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.107 AC: 16314AN: 152202Hom.: 1139 Cov.: 32 AF XY: 0.106 AC XY: 7871AN XY: 74408
GnomAD4 genome
AF:
AC:
16314
AN:
152202
Hom.:
Cov.:
32
AF XY:
AC XY:
7871
AN XY:
74408
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
509
ALSPAC
AF:
AC:
512
ESP6500AA
AF:
AC:
150
ESP6500EA
AF:
AC:
1282
ExAC
AF:
AC:
13808
Asia WGS
AF:
AC:
242
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 01, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Hereditary spastic paraplegia 45 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;D;D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;N;.
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;.
REVEL
Benign
Sift
Benign
T;T;.
Sift4G
Uncertain
T;T;D
Polyphen
B;B;.
Vest4
MPC
0.68
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at